Dr Julian Stolper
Dr Julian Stolper
Dr Julian Stolper earned his bachelor's in Biosciences from the University of Heidelberg, Germany in 2013. He continued at Heidelberg, completing his master's in Molecular Biosciences with a focus on Developmental Biology and Stem Cells in 2015.
In 2017, Julian began his PhD studies at the University of Melbourne, collaborating with both the Murdoch Children's Research Institute (MCRI) and the Australian Regenerative Medicine Institute (ARMI). His doctoral research explored innovative approaches to understanding heart development and disease.
From 2021 to 2024, he worked as a post-doctoral researcher at MCRI's Heart Regeneration and Disease group. There, he specialised in studying how chemotherapy affects the heart and developed methods to screen thousands of compounds for potential protective treatments.
Julian joined the Cancer Therapies group in 2024 as a programme manager. He now coordinates research focusing on reducing the side effects of cancer treatments and helps develop clinical trials to improve patient outcomes.
In 2017, Julian began his PhD studies at the University of Melbourne, collaborating with both the Murdoch Children's Research Institute (MCRI) and the Australian Regenerative Medicine Institute (ARMI). His doctoral research explored innovative approaches to understanding heart development and disease.
From 2021 to 2024, he worked as a post-doctoral researcher at MCRI's Heart Regeneration and Disease group. There, he specialised in studying how chemotherapy affects the heart and developed methods to screen thousands of compounds for potential protective treatments.
Julian joined the Cancer Therapies group in 2024 as a programme manager. He now coordinates research focusing on reducing the side effects of cancer treatments and helps develop clinical trials to improve patient outcomes.
Dr Julian Stolper earned his bachelor's in Biosciences from the University of Heidelberg, Germany in 2013. He continued at Heidelberg, completing his master's in Molecular Biosciences with a focus on Developmental Biology and Stem Cells in 2015.
In...
In...
Dr Julian Stolper earned his bachelor's in Biosciences from the University of Heidelberg, Germany in 2013. He continued at Heidelberg, completing his master's in Molecular Biosciences with a focus on Developmental Biology and Stem Cells in 2015.
In 2017, Julian began his PhD studies at the University of Melbourne, collaborating with both the Murdoch Children's Research Institute (MCRI) and the Australian Regenerative Medicine Institute (ARMI). His doctoral research explored innovative approaches to understanding heart development and disease.
From 2021 to 2024, he worked as a post-doctoral researcher at MCRI's Heart Regeneration and Disease group. There, he specialised in studying how chemotherapy affects the heart and developed methods to screen thousands of compounds for potential protective treatments.
Julian joined the Cancer Therapies group in 2024 as a programme manager. He now coordinates research focusing on reducing the side effects of cancer treatments and helps develop clinical trials to improve patient outcomes.
In 2017, Julian began his PhD studies at the University of Melbourne, collaborating with both the Murdoch Children's Research Institute (MCRI) and the Australian Regenerative Medicine Institute (ARMI). His doctoral research explored innovative approaches to understanding heart development and disease.
From 2021 to 2024, he worked as a post-doctoral researcher at MCRI's Heart Regeneration and Disease group. There, he specialised in studying how chemotherapy affects the heart and developed methods to screen thousands of compounds for potential protective treatments.
Julian joined the Cancer Therapies group in 2024 as a programme manager. He now coordinates research focusing on reducing the side effects of cancer treatments and helps develop clinical trials to improve patient outcomes.
Top Publications
- Stolper, J, Voges, HK, See, M, Mehdiabadi, NR, Chahal, G, Drvodelic, M, Eichenlaub, M, Labonne, T, Schultz, BG, Hidalgo, A, et al. The human FLT1 regulatory element directs vascular expression and modulates angiogenesis pathways in vitro and in vivo. 2026 view publication
- Bienroth, D, Charitakis, N, Wong, D, Jaeger-Honz, S, Garkov, D, Watt, KI, Stolper, J, Chambers-Smith, H, MacGregor, D, Christiansen, B, et al. Automated Integration of Multi-Slice Spatial Transcriptomics Data in 2D and 3D. 2026 view publication
- Walker, H, Selman, CJ, Goh, L-Y, Lee, KJ, Rombaldo, K, McLeman, L, Summers, P, Stolper, J, Hanna, D, Hughes, D, et al. “Validation of a novel ordinal endpoint for an adaptive platform trial in paediatric haematopoietic stem cell transplant”. 2026 view publication
- Khatri, D, Halman, A, Kausman, J, Mathew, J, Bannister, E, Stenta, T, Moore, C, Williams, E, Dyas, R, Stolper, J, et al. Protocol for Bayesian combined multi-genotype and concentration informed tacrolimus dosing in paediatric solid organ transplantation (BRUNO-PIC). 2026 view publication
- Collier, L, Grimshaw, SL, Stolper, J, Passmore, E, Ball, G, Elliott, DA, Conyers, R. Scoping review of the utilization of wearable devices in pediatric and young adult oncology.. NPJ Digit Med 8(1) : 488 2025 view publication
Page 1 of 4
Career information
Share //
